Merative logo

Merative

Cloud-based clinical data management for accelerating trial outcomes.

Visit website

Overview

Merative is a healthcare data and technology company that develops software, analytics, and decision-support solutions for a broad range of health and social care organisations. Its products serve healthcare providers, payers, pharmaceutical companies, government agencies, and clinical research organisations, with a stated reach of 187 million people served globally and operations spanning more than 80 countries. The company draws on more than 50 years of experience across its product lines.

Merative organises its portfolio around five core product families: Micromedex, Truven, Cúram, Merge, and Zelta, each targeting a distinct segment of the health and human services market.

Core Products and Modules

  • Micromedex – Evidence-based clinical decision support delivered at the point of care. Micromedex received a number-one ranking in the 2026 Best in KLAS report for Clinical Decision Support. It is used by 6 of the 10 top U.S. health systems, 10 of the 20 top U.S. hospitals, and is deployed across more than 5,500 sites in over 80 countries.
  • Truven – Healthcare data and analytics products designed to inform business decisions for payers, employers, and other healthcare organisations. Truven serves 7 of the 10 top U.S. payers, 40% of Fortune 100 employers, and more than 7,500 small- and mid-market employers. Its capabilities include predictive analytics and continuous measurement to support outcomes-driven decision-making.
  • Cúram – A health and human services platform for government agencies delivering modern benefits and social program administration. Cúram supports more than 970 social programs and approximately 200,000 caseworker users, serving 187 million people globally. A documented implementation at Minnesota Information Technology resulted in an increase in auto-renewal rates for MAGI Medicaid from 17% to 80%, with reported savings of 36,000 staff hours and approximately $1.3 million in one cohort.
  • Merge – Medical imaging solutions, including PACS and VNA capabilities, designed to enhance imaging workflows and optimise care delivery. Merge is used by 7 of the 10 top integrated delivery networks (IDNs) in the United States.
  • Zelta – A cloud-based clinical data management platform intended to accelerate clinical trial outcomes. Zelta is used by 17 of the 20 top pharmaceutical companies, supports more than 4,500 studies across all phases, and has been involved in more than 500 Phase III clinical trials across more than 100 countries. Users have reported building initial studies within two weeks of adoption.

Core Capabilities

  • Evidence-based clinical decision support integrated into clinical workflows, including applications in pharmacy practice, clinical toxicology, medication safety, and nursing practice.
  • Real-world evidence and healthcare analytics through datasets such as MarketScan, which supports research including pharmacovigilance and drug safety studies. Researchers have used MarketScan data in custom data-linking projects, with one institution reporting that access to large, clean datasets could reduce the time to identify fetal toxicities from approximately 10 years to fewer than 5.
  • Government social services transformation through the Cúram platform, enabling modernisation of benefits delivery and caseworker efficiency.
  • Medical imaging workflow optimisation, from image acquisition through final diagnostic read, with scalable infrastructure for health systems of varying sizes.
  • Cloud-based clinical data management for pharmaceutical and clinical research organisations, supporting study build, data collection, and trial management across all development phases.
  • Integration of artificial intelligence across product lines, including AI applications in clinical decision support, pharmacy practice, clinical toxicology, conversational interfaces, and nursing workflows.

Customers and Market Reach

  • 6 of the 10 top U.S. health systems and 10 of the 20 top U.S. hospitals use Merative products.
  • 7 of the 10 top U.S. payers rely on Truven analytics.
  • 17 of the 20 top pharmaceutical companies use Zelta for clinical data management.
  • 7 of the 10 top U.S. integrated delivery networks use Merge imaging solutions.
  • 40% of Fortune 100 employers and more than 7,500 small- and mid-market employers are served through Truven.
  • Government and social services clients include state-level agencies such as Minnesota Information Technology, with Cúram deployed across more than 970 social programs worldwide.

Notable Details

  • Merative publishes editorial content across topic areas including clinical decision support, real-world evidence, healthcare analytics, clinical development, medical imaging, and health and human services, authored by clinicians, pharmacists, and data scientists.
  • The company's products span both provider-facing clinical tools and payer- or employer-facing analytics, as well as government-facing case management and pharmaceutical research platforms, reflecting a broad cross-sector positioning within health and social care.
  • Zelta is described as cloud-based, supporting flexible deployment for clinical research organisations and pharmaceutical sponsors.
  • Micromedex has been in continuous use at some institutions for more than 40 years, according to customer testimony.

Merative's portfolio addresses multiple points in the health and social care continuum, from clinical decision-making at the bedside and imaging in radiology departments, to government benefits administration, employer health analytics, and pharmaceutical clinical trial management.